RC

Rakesh Chandru Vanjani

Director Director DIN 08165944
DIN 08165944 First appointment Jun 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2018
Shareholding value •••• Premium profile

About Rakesh Chandru Vanjani

Data last updated:

Rakesh Chandru Vanjani was a Director at Genekon Pharmaceutical Private Limited (2022–2023) and Director at Traavi Tech Private Limited (2018–2020). The companies operate in Pharma and Information Technology.

DIN 08165944
Primary Designation Director
Industry Pharma
First Appointment 28 Jun 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Nov 20222015Active
Traavi Tech Private Limited U72900WB2017PTC219540
Director28 Jun 20182017₹1.75 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Genekon Pharmaceutical Private Limited
Traavi Tech Private Limited
Premium access

Shareholding and investment profile for Rakesh Chandru Vanjani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Chandru Vanjani

Rakesh Chandru Vanjani was first appointed on 28 Jun 2018 as Director at Traavi Tech Private Limited. The most recent appointment on record is 24 Nov 2022 at Genekon Pharmaceutical Private Limited.

Rakesh Chandru Vanjani held 2 earlier board appointments: Genekon Pharmaceutical Private Limited (Director, 24 Nov 2022 to 28 Aug 2023); Traavi Tech Private Limited (Director, 28 Jun 2018 to 19 Mar 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available